Trial intelligence / Profile preview

EOF5 Regimen in Advanced and Metastatic Gastric Cancer

NCT00767377Phase 2Completed

Sponsor
Fudan University
Start
May 2007
Primary completion
Jul 2012
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 2 trial of oxaliplatin in gastric cancer (GC), sponsored by Fudan University. Started May 2007; status: completed.

02

Drugs

oxaliplatin
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT00767377.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00767377.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call